Bioequivalence Between two different formulations [Regulatives / Guidelines]

posted by valivetiananth – India, 2016-10-29 15:07 (3526 d 04:53 ago) – Posting: # 16756
Views: 3,896

Dear All,

The innovator formulation is soft gelatin capsules and we are proposing a hard gelatin capsules of same strength. The pilot study was conducted b/w two dosage forms in a crossover pattern. The study reveals that, the soft gelatin capsule is exhibiting higher concentrations than the hard gelatin capsules but there is no difference in tmax.


Guide me which type of study is required to prove bioequivalence for FDA submission.


Regards
Valiveti

Complete thread:

UA Flag
Activity
 Admin contact
23,655 posts in 4,993 threads, 1,571 registered users;
170 visitors (0 registered, 170 guests [including 36 identified bots]).
Forum time: 20:01 CEST (Europe/Vienna)

The great tragedy of Science – the slaying
of a beautiful hypothesis by an ugly fact.    Thomas Henry Huxley

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5